Related Experiment Video
Updated: Feb 2, 2026
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
The Mitochondrial tRNAGly T10003C Mutation may not be Associated with Diabetes Mellitus
1Department of Endocrinology and Metabolism, People's Hospital of Zhengzhou University, Zhengzhou, Henan Province, Zhengzhou People's Republic of China.
Abstract:
Mitochondrial DNA (mtDNA) mutations have long been proposed to play important roles in the pathogenesis of diabetes mellitus (DM). A large proportion of these mutations are localized at the mt-tRNA genes. Owing to its high mutation rate, a growing number of mt-tRNA mutations have been reported; however some of them are neutral genetic polymorphisms and will not result in the alteration of the mitochondrial function responsible for DM. In this study, we reassessed a recent reported "pathogenic" mutation, tRNAGly T10003C, in a clinical manifestation of DM. We first performed the conservation assessment of this mutation between different species. Moreover, the bioinformatics analysis was used to predict the secondary structure of mt-tRNAGly in wild type version and the mutant carrying the T10003C mutation. We also screened the presence of the T10003C mutation in 500 unrelated DM patients and 300 healthy controls. We noticed that the T10003C mutation was not very conserved and did not cause the secondary structure change of mt-tRNAGly. Moreover, this mutation was absent in the 500 unrelated DM patients and controls, suggesting that this mutation may be a rare event in the human population. In conclusion, the current study showed no association between the T10003C mutation and DM in humans.
Insights
Mitochondrial DNA mutations are linked to diabetes mellitus (DM). This study found the tRNA Gly T10003C mutation is not associated with DM, suggesting it is a rare, non-pathogenic polymorphism.
Area of Science:
- Genetics
- Molecular Biology
- Metabolic Diseases
Background:
- Mitochondrial DNA (mtDNA) mutations, particularly in mt-tRNA genes, are implicated in diabetes mellitus (DM) pathogenesis.
- However, distinguishing pathogenic mutations from neutral polymorphisms is crucial for understanding DM etiology.
Purpose of the Study:
- To re-evaluate the clinical significance of the reported "pathogenic" mitochondrial tRNA Gly T10003C mutation in diabetes mellitus.
- To determine if this specific mutation is associated with DM in the human population.
Main Methods:
- Cross-species conservation assessment of the T10003C mutation.
- Bioinformatic prediction of mt-tRNA Gly secondary structure (wild-type vs. mutant).
- Screening for the T10003C mutation in 500 DM patients and 300 healthy controls.
Main Results:
- The T10003C mutation exhibited low interspecies conservation.
- Bioinformatics analysis revealed no significant alteration in the mt-tRNA Gly secondary structure due to the T10003C mutation.
- The T10003C mutation was absent in both DM patients and healthy controls, indicating its rarity.
Conclusions:
- The tRNA Gly T10003C mutation is not conserved across species and does not disrupt mt-tRNA Gly secondary structure.
- No association was found between the T10003C mutation and diabetes mellitus in the studied human cohorts.
- This suggests the T10003C mutation is likely a rare, neutral polymorphism rather than a pathogenic factor in DM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:39Mutations
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:59Animal Mitochondrial Genetics
02:19Export of Mitochondrial and Chloroplast Genes